P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

• Koray Yalcin,
• Ebru Erdogan,
• Rehile Zengin,
• Tulay Ozcelik,
• Nurcan Ozcelik Kurkcu,
• Hakan Ozdogu,
• Cem Kis,
• Gozde Sir Karakus,
• Selin Gunaydin,
• Utku Seyis,
• Siret Ratip,
• Ercument Ovali

Affiliations

Koray Yalcin

1 Acibadem University Medical Biotechnology, İstanbul, Turkey

Ebru Erdogan

4 Acibadem Altunizade Hospital, Hematology, Turkey

Rehile Zengin

5 Acibadem Altunizade Hospital, Infectious Disease, Turkey

Tulay Ozcelik

6 Bilim University İstanbul Florence Nightingale Hospital, Turkey

Nurcan Ozcelik Kurkcu

6 Bilim University İstanbul Florence Nightingale Hospital, Turkey

Hakan Ozdogu

7 Baskent University School of Medicine Hematology Department, Turkey

Cem Kis

7 Baskent University School of Medicine Hematology Department, Turkey

Gozde Sir Karakus

3 Acibadem Labcell Cellular Therapy Center, Turkey

Selin Gunaydin

3 Acibadem Labcell Cellular Therapy Center, Turkey

Utku Seyis

3 Acibadem Labcell Cellular Therapy Center, Turkey

Siret Ratip

4 Acibadem Altunizade Hospital, Hematology, Turkey

Ercument Ovali

3 Acibadem Labcell Cellular Therapy Center, Turkey